May oxytocin be a trait marker for bipolar disorder?

Psychoneuroendocrinology

Volumn 38, Issue 12, 2013, Pages 2890-2896

  Turan, Tayfun ^a   Uysal, Cengiz ^b   Asdemir, Akif ^a   Kiliç, Eser ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b AHI EVRAN UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Bipolar remission; Depressive episode; Manic episode; Oxytocin; Treatment response

Indexed keywords

BIOLOGICAL MARKER; OXYTOCIN;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DSM-IV-TR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MULTIVARIATE ANALYSIS OF COVARIANCE; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE;

BIPOLAR DISORDER; BIPOLAR REMISSION; DEPRESSIVE EPISODE; MANIC EPISODE; OXYTOCIN; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BODY MASS INDEX; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYTOCIN; PSYCHIATRIC STATUS RATING SCALES; SMOKING; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84888290215     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.07.017     Document Type: Article

References (35)

1. Akiskal H. Mood disorder. Kaplan and Sadock's Comprehensive Textbook of Psychiatry 2009, 1632. Lippincott Williams and Wilkins, Philadelphia. 9th ed. B.J.S.V. Sadock (Ed.).
2. American Psychiatric Association, American Psychiatric Association and Task Force on DSM-IV Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th ed.
3. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 2008, 57:531-553.
4. Baskerville T.A., Douglas A.J. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci. Ther. 2010, 16:e92-e123.
5. Bosch O.J., Neumann I.D. Both oxytocin and vasopressin are mediators of maternal care and aggression in rodents: from central release to sites of action. Horm. Behav. 2012, 61:293-303.
6. Caldwell H.K., Lee H.-J., Macbeth A.H., Young Iii W.S. Vasopressin: behavioral roles of an original neuropeptide. Prog. Neurobiol. 2008, 84:1-24.
7. Carter C.S., Altemus M., Chrousos G.P. Neuroendocrine and emotional changes in the post-partum period. Prog. Brain Res. 2001, 133:241-249.
8. Cyranowski J.M., Hofkens T.L., Frank E., Seltman H., Cai H.M., Amico J.A. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom. Med. 2008, 70:967-975.
9. Feldman R. Oxytocin and social affiliation in humans. Horm. Behav. 2012, 61:380-391.
10. Gordon I., Zagoory-Sharon O., Schneiderman I., Leckman J.F., Weller A., Feldman R. Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress. Psychophysiology 2008, 45:349-352.
11. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-61.
12. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
13. Heinrichs M., von Dawans B., Domes G. Oxytocin, vasopressin, and human social behavior. Front. Neuroendocrinol. 2009, 30:548-557.
14. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308:245-248.
15. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
16. Lee H.J., Macbeth A.H., Pagani J.H., Young W.S. Oxytocin: the great facilitator of life. Prog. Neurobiol. 2009, 88:127-151.
17. Liu Y., Wang Z.X. Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 2003, 121:537-544.
18. Marazziti D., Catena Dell'osso M. The role of oxytocin in neuropsychiatric disorders. Curr. Med. Chem. 2008, 15:698-704.
19. McGregor I.S., Bowen M.T. Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm. Behav. 2012, 61:331-339.
20. Meynen G., Unmehopa U.A., Hofman M.A., Swaab D.F., Hoogendijk W.J. Hypothalamic oxytocin mRNA expression and melancholic depression. Mol. Psychiatry 2007, 12:118-119.
21. Neumann I.D. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog. Brain Res. 2002, 139:147-162.
22. Neumann I.D., Kromer S.A., Toschi N., Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul. Pept. 2000, 96:31-38.
23. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659.
24. Neumann I.D., Torner L., Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 2000, 95:567-575.
25. Ozsoy S., Esel E., Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res. 2009, 169:249-252.
26. Parker K.J., Buckmaster C.L., Schatzberg A.F., Lyons D.M. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology 2005, 30:924-929.
27. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., Schatzberg A.F. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res. 2010, 178:359-362.
28. Pitchot W., Scantamburlo G., Pinto E., Hansenne M., Reggers J., Ansseau M., Legros J.J. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior. J. Psychiatr. Res. 2008, 42:684-688.
29. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
30. Rubin L.H., Carter C.S., Drogos L., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr. Res. 2010, 124:13-21.
31. Smeltzer M.D., Curtis J.T., Aragona B.J., Wang Z. Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles. Neurosci. Lett. 2006, 394:146-151.
32. Succu S., Sanna F., Melis T., Boi A., Argiolas A., Melis M.R. Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin. Neuropharmacology 2007, 52:1034-1043.
33. Uvnas-Moberg K., Alster P., Svensson T.H. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats. Psychopharmacology (Berl) 1992, 109:473-476.
34. Uvnas-Moberg K., Bjokstrand E., Hillegaart V., Ahlenius S. Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl) 1999, 142:95-101.
35. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.